Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

Journal of Clinical Oncology

Volumn 20, Issue 1, 2002, Pages 142-152

  Toso, John F ^a   Gill, Vee J ^a   Hwu, Patrick ^a   Marincola, Francesco M ^a   Restifo, Nicholas P ^a   Schwartzentruber, Douglas J ^a   Sherry, Richard M ^a   Topalian, Suzanne L ^a   Yang, James C ^a   Stock, Frida ^a   Freezer, Linda J ^a   Morton, Kathleen E ^a   Seipp, Claudia ^a   Haworth, Leah ^a   Mavroukakis, Sharon ^a   White, Donald ^a   MacDonald, Susan ^a   Mao, John ^a   Sznol, Mario ^a   Rosenberg, Steven A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; GENE PRODUCT; PROTEIN MSBB; PROTEIN PUR1; UNCLASSIFIED DRUG; VNP 20009;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTEREMIA; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGRESSION; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPOPHOSPHATEMIA; KIDNEY CARCINOMA; MALE; MELANOMA; METASTASIS; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; THROMBOCYTOPENIA; TREATMENT PLANNING; VOMITING;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTINEOPLASTIC AGENTS; BACTERIAL TRANSLOCATION; CARCINOMA, RENAL CELL; COLONY COUNT, MICROBIAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENETIC ENGINEERING; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MIDDLE AGED; SALMONELLA TYPHIMURIUM;

EID: 0036140068     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.1.142     Document Type: Article

References (21)

1. Tumor-targeted Salmonella as a novel anticancer vector
2. Lipid A mutant Salmonella with suppressed virulence and TNF-α induction retain tumor-targeting in vivo
3. Abscess formation in pheochromocytoma
4. Salmonellosis: An unusual complication of hepatocellular carcinoma
5. Abscess caused by Salmonella enteritidis within a glioblastoma multiforme
6. Salmonellosis: A review of some unusual aspects
7. Salmonella focal intracranial infections: Review of the world literature (1884-1984) and report of an unusual case
8. Infection of a secondary carcinoma by Salmonella montevideo
9. A lethal role for lipid A in Salmonella infection
10. VNP20009, a genetically modified Salmonella typhimurium for the treatment of solid tumors
11. Biodistribution and genetic stability of the novel antitumor agent VNP 20009, a genetically modified strain of Salmonella typhimurium
12. Genetically modified Salmonella typhimurium inhibited growth of primary tumors and metastases
13. Regulation of the proinflammatory effects of Fas ligand (CD95L)
14. Salmonella-induced caspase-2 activation in macrophages: A novel mechanism in pathogen-mediated apoptosis
15. Expression of human IL-1 beta in Salmonella typhimurium: A model system for the delivery of recombinant therapeutic proteins in vivo
16. Antitumor mechanism of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent?
17. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
18. Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IkappaB alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction
19. Proinflammatory cytokines
20. Induction of tolerance to LPS-Dgalactosamine lethality by pretreatment with LPS is mediated by macrophages
21. Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer